Pharmaceutical company Pfizer has started its application to the U.S. Food and Drug Administration for full approval of its COVID-19 vaccine. Since December, Pfizer has been authorized on an emergency ...

May 23 (Reuters) - Moderna (MRNA.O), opens new tab said on Friday it has filed a marketing application for the review of its updated COVID-19 vaccine with the U.S. Food and Drug Administration. The ...

Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...

Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) seeking approval for its COVID-19 and Influenza combination vaccine for ...

Add Yahoo as a preferred source to see more of our stories on Google. Illustration shows Moderna logo (Reuters) -Moderna said on Friday it has filed a marketing application for the review of its ...